A study comparing cervical pessary and vaginal progesterone for the prevention of preterm birth in women with a short cervix of ≤ 35 mm found no significant difference between the interventions for ...

Women with a short cervix around 20 weeks of pregnancy have an increased risk of preterm birth. Preventing preterm birth in pregnant women with a short cervix is a crucial step in protecting the ...

Women with a short cervix treated with a cervical pessary for the prevention of early preterm birth are equally as likely as those treated with vaginal progesterone to give birth before 34 weeks of ...

Women with a short cervix around 20 weeks of pregnancy have an increased risk of preterm birth. Preventing preterm birth in pregnant women with a short cervix is a crucial step in protecting the ...

Having twins accounts for only 1.5% of all births but 25% of preterm births, the leading cause of infant mortality worldwide. Successful strategies for reducing singleton preterm births include ...

Sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation with a ...

Please provide your email address to receive an email when new articles are posted on . Preterm delivery or neonatal death occurred in 45.5% of the pessary group vs. 45.6% of the usual care group.

Cervical pessaries didn't reduce risk of preterm birth and fetal death prior to 37 weeks gestation in high-risk singleton pregnancies, according to the randomized TOPS trial. The intravaginal device ...

Preterm birth or birth before 37 weeks of gestation, is a major global health concern, significantly contributing to infant mortality and long-term health issues. According to the World Health ...